The Coxsackie-IgG Type A7 (IFT) test looks for long-term (IgG) antibodies against Coxsackievirus A7, a member of the enterovirus family. It’s performed by indirect immunofluorescence (IFT), which reports a qualitative/semiquantitative signal (often as a titer or index). IgG indicates past exposure and immune memory—not necessarily a current infection. Many people encounter enteroviruses in childhood; therefore, positive or elevated IgG is common and usually reflects previous infection or vaccination status (no routine vaccine exists for A7) rather than active disease. Because IFT can show cross-reactivity across enteroviruses (and labs use different cutoffs), interpretation hinges on clinical context, the exact titer/index, and paired testing when needed. If you’re evaluating a current illness (e.g., fever, sore throat, herpangina-like mouth ulcers, hand-foot-mouth disease, aseptic meningitis, or myocarditis workups), IgG alone can’t confirm timing—consider IgM, PCR/NAAT from relevant samples (throat/nasopharynx swab, stool, CSF, or lesion swab), and acute-and-convalescent sera (a fourfold IgG rise over 2–4 weeks supports recent infection). In asymptomatic individuals, an isolated elevated IgG generally requires no treatment. For symptomatic patients, management is supportive unless another diagnosis or complication is identified. Always interpret using the performing lab’s reference ranges and alongside your symptoms, exam, and other tests.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.